409 related articles for article (PubMed ID: 29893593)
1. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
[TBL] [Abstract][Full Text] [Related]
2. High frequencies of dermatological complications in children using insulin pumps or sensors.
Berg AK; Olsen BS; Thyssen JP; Zachariae C; Simonsen AB; Pilgaard K; Svensson J
Pediatr Diabetes; 2018 Jun; 19(4):733-740. PubMed ID: 29484783
[TBL] [Abstract][Full Text] [Related]
3. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Rubin RR; Peyrot M
J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
Front Public Health; 2022; 10():990281. PubMed ID: 36091534
[TBL] [Abstract][Full Text] [Related]
5. Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.
Christensen MO; Berg AK; Rytter K; Hommel E; Thyssen JP; Svensson J; Nørgaard K
Diabetes Technol Ther; 2019 Apr; 21(4):215-221. PubMed ID: 30943072
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
[TBL] [Abstract][Full Text] [Related]
7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
8. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
9. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
[TBL] [Abstract][Full Text] [Related]
11. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
12. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
Diedisheim M; Pecquet C; Julla JB; Carlier A; Potier L; Hartemann A; Jacqueminet S; Vidal-Trecan T; Gautier JF; Dubois Laforgue D; Fagherazzi G; Roussel R; Larger E; Sola-Gazagnes A; Riveline JP
Diabetes Technol Ther; 2023 Apr; 25(4):279-286. PubMed ID: 36763338
[No Abstract] [Full Text] [Related]
14. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.
Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Hamblin PS; O'Connell MA; Rodda C; Teede H; O'Neal DN
Diabetes Technol Ther; 2011 Feb; 13(2):105-9. PubMed ID: 21284476
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment.
Joubert M; Morera J; Vicente A; Rod A; Parienti JJ; Reznik Y
J Diabetes Sci Technol; 2014 Sep; 8(5):1005-10. PubMed ID: 24876454
[TBL] [Abstract][Full Text] [Related]
16. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
Telo GH; Volkening LK; Butler DA; Laffel LM
Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
18. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
Rodbard D; Jovanovic L; Garg SK
Diabetes Technol Ther; 2009 Dec; 11(12):757-65. PubMed ID: 20001676
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
[TBL] [Abstract][Full Text] [Related]
20. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
